Position in RYTM
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$582,438
New position
Shares Held
6,697
first reported quarter
Ownership
0.010%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026IMC-Chicago, LLC holds $54,107,382 across 30 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
87,392 | $11,645,857 | |
| 2 | INSM |
INSMED Inc
|
76,126 | $8,116,554 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
10,847 | $5,824,296 | |
| 4 | CELC |
Celcuity Inc.
|
41,127 | $4,302,706 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,591 | $3,486,212 | |
| 6 | BNTX |
BioNTech SE
|
29,282 | $2,724,690 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
10,187 | $2,493,471 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
68,630 | $2,428,815 |
All Filings in RYTM
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $582,438 | 6,697 | Shares | Sole | 2026-05-05 | |
| No filing history on record for this holder in this stock. | ||||||